Copyright Reports & Markets. All rights reserved.

Global Hereditary Disease Testing Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope of Hereditary Disease Testing
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Hereditary Disease Testing by Type
    • 1.3.1 Overview: Global Hereditary Disease Testing Market Size by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Global Hereditary Disease Testing Consumption Value Market Share by Type in 2022
    • 1.3.3 Hereditary Cancer Testing
    • 1.3.4 Hereditary Non-cancer Testing
  • 1.4 Global Hereditary Disease Testing Market by Application
    • 1.4.1 Overview: Global Hereditary Disease Testing Market Size by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Hospital
    • 1.4.3 Clinic
    • 1.4.4 Laboratory
    • 1.4.5 Others
  • 1.5 Global Hereditary Disease Testing Market Size & Forecast
  • 1.6 Global Hereditary Disease Testing Market Size and Forecast by Region
    • 1.6.1 Global Hereditary Disease Testing Market Size by Region: 2018 VS 2022 VS 2029
    • 1.6.2 Global Hereditary Disease Testing Market Size by Region, (2018-2029)
    • 1.6.3 North America Hereditary Disease Testing Market Size and Prospect (2018-2029)
    • 1.6.4 Europe Hereditary Disease Testing Market Size and Prospect (2018-2029)
    • 1.6.5 Asia-Pacific Hereditary Disease Testing Market Size and Prospect (2018-2029)
    • 1.6.6 South America Hereditary Disease Testing Market Size and Prospect (2018-2029)
    • 1.6.7 Middle East and Africa Hereditary Disease Testing Market Size and Prospect (2018-2029)

2 Company Profiles

  • 2.1 Myriad Genetics
    • 2.1.1 Myriad Genetics Details
    • 2.1.2 Myriad Genetics Major Business
    • 2.1.3 Myriad Genetics Hereditary Disease Testing Product and Solutions
    • 2.1.4 Myriad Genetics Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Myriad Genetics Recent Developments and Future Plans
  • 2.2 Invitae
    • 2.2.1 Invitae Details
    • 2.2.2 Invitae Major Business
    • 2.2.3 Invitae Hereditary Disease Testing Product and Solutions
    • 2.2.4 Invitae Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Invitae Recent Developments and Future Plans
  • 2.3 Illumina
    • 2.3.1 Illumina Details
    • 2.3.2 Illumina Major Business
    • 2.3.3 Illumina Hereditary Disease Testing Product and Solutions
    • 2.3.4 Illumina Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Illumina Recent Developments and Future Plans
  • 2.4 Natera
    • 2.4.1 Natera Details
    • 2.4.2 Natera Major Business
    • 2.4.3 Natera Hereditary Disease Testing Product and Solutions
    • 2.4.4 Natera Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Natera Recent Developments and Future Plans
  • 2.5 Laboratory Corporation of America Holdings
    • 2.5.1 Laboratory Corporation of America Holdings Details
    • 2.5.2 Laboratory Corporation of America Holdings Major Business
    • 2.5.3 Laboratory Corporation of America Holdings Hereditary Disease Testing Product and Solutions
    • 2.5.4 Laboratory Corporation of America Holdings Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Laboratory Corporation of America Holdings Recent Developments and Future Plans
  • 2.6 F. Hoffmann-La Roche
    • 2.6.1 F. Hoffmann-La Roche Details
    • 2.6.2 F. Hoffmann-La Roche Major Business
    • 2.6.3 F. Hoffmann-La Roche Hereditary Disease Testing Product and Solutions
    • 2.6.4 F. Hoffmann-La Roche Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 F. Hoffmann-La Roche Recent Developments and Future Plans
  • 2.7 Quest Diagnostics
    • 2.7.1 Quest Diagnostics Details
    • 2.7.2 Quest Diagnostics Major Business
    • 2.7.3 Quest Diagnostics Hereditary Disease Testing Product and Solutions
    • 2.7.4 Quest Diagnostics Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Quest Diagnostics Recent Developments and Future Plans
  • 2.8 CooperSurgical
    • 2.8.1 CooperSurgical Details
    • 2.8.2 CooperSurgical Major Business
    • 2.8.3 CooperSurgical Hereditary Disease Testing Product and Solutions
    • 2.8.4 CooperSurgical Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 CooperSurgical Recent Developments and Future Plans
  • 2.9 Agilent Technologies
    • 2.9.1 Agilent Technologies Details
    • 2.9.2 Agilent Technologies Major Business
    • 2.9.3 Agilent Technologies Hereditary Disease Testing Product and Solutions
    • 2.9.4 Agilent Technologies Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Agilent Technologies Recent Developments and Future Plans
  • 2.10 Thermo Fisher Scientific
    • 2.10.1 Thermo Fisher Scientific Details
    • 2.10.2 Thermo Fisher Scientific Major Business
    • 2.10.3 Thermo Fisher Scientific Hereditary Disease Testing Product and Solutions
    • 2.10.4 Thermo Fisher Scientific Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Thermo Fisher Scientific Recent Developments and Future Plans
  • 2.11 Twist Bioscience
    • 2.11.1 Twist Bioscience Details
    • 2.11.2 Twist Bioscience Major Business
    • 2.11.3 Twist Bioscience Hereditary Disease Testing Product and Solutions
    • 2.11.4 Twist Bioscience Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Twist Bioscience Recent Developments and Future Plans
  • 2.12 Sophia Genetics
    • 2.12.1 Sophia Genetics Details
    • 2.12.2 Sophia Genetics Major Business
    • 2.12.3 Sophia Genetics Hereditary Disease Testing Product and Solutions
    • 2.12.4 Sophia Genetics Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 Sophia Genetics Recent Developments and Future Plans
  • 2.13 Fulgent Genetic
    • 2.13.1 Fulgent Genetic Details
    • 2.13.2 Fulgent Genetic Major Business
    • 2.13.3 Fulgent Genetic Hereditary Disease Testing Product and Solutions
    • 2.13.4 Fulgent Genetic Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.13.5 Fulgent Genetic Recent Developments and Future Plans
  • 2.14 Medgenome
    • 2.14.1 Medgenome Details
    • 2.14.2 Medgenome Major Business
    • 2.14.3 Medgenome Hereditary Disease Testing Product and Solutions
    • 2.14.4 Medgenome Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.14.5 Medgenome Recent Developments and Future Plans
  • 2.15 CENTOGENE
    • 2.15.1 CENTOGENE Details
    • 2.15.2 CENTOGENE Major Business
    • 2.15.3 CENTOGENE Hereditary Disease Testing Product and Solutions
    • 2.15.4 CENTOGENE Hereditary Disease Testing Revenue, Gross Margin and Market Share (2018-2023)
    • 2.15.5 CENTOGENE Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Hereditary Disease Testing Revenue and Share by Players (2018-2023)
  • 3.2 Market Share Analysis (2022)
    • 3.2.1 Market Share of Hereditary Disease Testing by Company Revenue
    • 3.2.2 Top 3 Hereditary Disease Testing Players Market Share in 2022
    • 3.2.3 Top 6 Hereditary Disease Testing Players Market Share in 2022
  • 3.3 Hereditary Disease Testing Market: Overall Company Footprint Analysis
    • 3.3.1 Hereditary Disease Testing Market: Region Footprint
    • 3.3.2 Hereditary Disease Testing Market: Company Product Type Footprint
    • 3.3.3 Hereditary Disease Testing Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Hereditary Disease Testing Consumption Value and Market Share by Type (2018-2023)
  • 4.2 Global Hereditary Disease Testing Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

  • 5.1 Global Hereditary Disease Testing Consumption Value Market Share by Application (2018-2023)
  • 5.2 Global Hereditary Disease Testing Market Forecast by Application (2024-2029)

6 North America

  • 6.1 North America Hereditary Disease Testing Consumption Value by Type (2018-2029)
  • 6.2 North America Hereditary Disease Testing Consumption Value by Application (2018-2029)
  • 6.3 North America Hereditary Disease Testing Market Size by Country
    • 6.3.1 North America Hereditary Disease Testing Consumption Value by Country (2018-2029)
    • 6.3.2 United States Hereditary Disease Testing Market Size and Forecast (2018-2029)
    • 6.3.3 Canada Hereditary Disease Testing Market Size and Forecast (2018-2029)
    • 6.3.4 Mexico Hereditary Disease Testing Market Size and Forecast (2018-2029)

7 Europe

  • 7.1 Europe Hereditary Disease Testing Consumption Value by Type (2018-2029)
  • 7.2 Europe Hereditary Disease Testing Consumption Value by Application (2018-2029)
  • 7.3 Europe Hereditary Disease Testing Market Size by Country
    • 7.3.1 Europe Hereditary Disease Testing Consumption Value by Country (2018-2029)
    • 7.3.2 Germany Hereditary Disease Testing Market Size and Forecast (2018-2029)
    • 7.3.3 France Hereditary Disease Testing Market Size and Forecast (2018-2029)
    • 7.3.4 United Kingdom Hereditary Disease Testing Market Size and Forecast (2018-2029)
    • 7.3.5 Russia Hereditary Disease Testing Market Size and Forecast (2018-2029)
    • 7.3.6 Italy Hereditary Disease Testing Market Size and Forecast (2018-2029)

8 Asia-Pacific

  • 8.1 Asia-Pacific Hereditary Disease Testing Consumption Value by Type (2018-2029)
  • 8.2 Asia-Pacific Hereditary Disease Testing Consumption Value by Application (2018-2029)
  • 8.3 Asia-Pacific Hereditary Disease Testing Market Size by Region
    • 8.3.1 Asia-Pacific Hereditary Disease Testing Consumption Value by Region (2018-2029)
    • 8.3.2 China Hereditary Disease Testing Market Size and Forecast (2018-2029)
    • 8.3.3 Japan Hereditary Disease Testing Market Size and Forecast (2018-2029)
    • 8.3.4 South Korea Hereditary Disease Testing Market Size and Forecast (2018-2029)
    • 8.3.5 India Hereditary Disease Testing Market Size and Forecast (2018-2029)
    • 8.3.6 Southeast Asia Hereditary Disease Testing Market Size and Forecast (2018-2029)
    • 8.3.7 Australia Hereditary Disease Testing Market Size and Forecast (2018-2029)

9 South America

  • 9.1 South America Hereditary Disease Testing Consumption Value by Type (2018-2029)
  • 9.2 South America Hereditary Disease Testing Consumption Value by Application (2018-2029)
  • 9.3 South America Hereditary Disease Testing Market Size by Country
    • 9.3.1 South America Hereditary Disease Testing Consumption Value by Country (2018-2029)
    • 9.3.2 Brazil Hereditary Disease Testing Market Size and Forecast (2018-2029)
    • 9.3.3 Argentina Hereditary Disease Testing Market Size and Forecast (2018-2029)

10 Middle East & Africa

  • 10.1 Middle East & Africa Hereditary Disease Testing Consumption Value by Type (2018-2029)
  • 10.2 Middle East & Africa Hereditary Disease Testing Consumption Value by Application (2018-2029)
  • 10.3 Middle East & Africa Hereditary Disease Testing Market Size by Country
    • 10.3.1 Middle East & Africa Hereditary Disease Testing Consumption Value by Country (2018-2029)
    • 10.3.2 Turkey Hereditary Disease Testing Market Size and Forecast (2018-2029)
    • 10.3.3 Saudi Arabia Hereditary Disease Testing Market Size and Forecast (2018-2029)
    • 10.3.4 UAE Hereditary Disease Testing Market Size and Forecast (2018-2029)

11 Market Dynamics

  • 11.1 Hereditary Disease Testing Market Drivers
  • 11.2 Hereditary Disease Testing Market Restraints
  • 11.3 Hereditary Disease Testing Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Hereditary Disease Testing Industry Chain
  • 12.2 Hereditary Disease Testing Upstream Analysis
  • 12.3 Hereditary Disease Testing Midstream Analysis
  • 12.4 Hereditary Disease Testing Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Hereditary Disease Testing market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period.
    The Global Info Research report includes an overview of the development of the Hereditary Disease Testing industry chain, the market status of Hospital (Hereditary Cancer Testing, Hereditary Non-cancer Testing), Clinic (Hereditary Cancer Testing, Hereditary Non-cancer Testing), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Hereditary Disease Testing.
    Regionally, the report analyzes the Hereditary Disease Testing markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Hereditary Disease Testing market, with robust domestic demand, supportive policies, and a strong manufacturing base.
    Key Features:
    The report presents comprehensive understanding of the Hereditary Disease Testing market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Hereditary Disease Testing industry.
    The report involves analyzing the market at a macro level:
    Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Hereditary Cancer Testing, Hereditary Non-cancer Testing).
    Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Hereditary Disease Testing market.
    Regional Analysis: The report involves examining the Hereditary Disease Testing market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
    Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Hereditary Disease Testing market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
    The report also involves a more granular approach to Hereditary Disease Testing:
    Company Analysis: Report covers individual Hereditary Disease Testing players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
    Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Hereditary Disease Testing This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Clinic).
    Technology Analysis: Report covers specific technologies relevant to Hereditary Disease Testing. It assesses the current state, advancements, and potential future developments in Hereditary Disease Testing areas.
    Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Hereditary Disease Testing market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
    Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
    Market Segmentation
    Hereditary Disease Testing market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
    Market segment by Type
    Hereditary Cancer Testing
    Hereditary Non-cancer Testing
    Market segment by Application
    Hospital
    Clinic
    Laboratory
    Others
    Market segment by players, this report covers
    Myriad Genetics
    Invitae
    Illumina
    Natera
    Laboratory Corporation of America Holdings
    F. Hoffmann-La Roche
    Quest Diagnostics
    CooperSurgical
    Agilent Technologies
    Thermo Fisher Scientific
    Twist Bioscience
    Sophia Genetics
    Fulgent Genetic
    Medgenome
    CENTOGENE
    Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Hereditary Disease Testing product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Hereditary Disease Testing, with revenue, gross margin and global market share of Hereditary Disease Testing from 2018 to 2023.
    Chapter 3, the Hereditary Disease Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Hereditary Disease Testing market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
    Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Hereditary Disease Testing.
    Chapter 13, to describe Hereditary Disease Testing research findings and conclusion.

    Buy now